SCHEMBL18593335

SCHEMBL18593335

CC(C)(C)c1cc(C(C)(C)C)c2oc(-c3ccc(F)cc3)nc2c1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 2/20 0.43
▸ RAB9A P51151 2/20 0.43
▸ GFER P55789 1/20 0.43
▸ CETP P11597 2/20 0.40
▸ ESR1 P03372 5/20 0.40
▸ ESR2 Q92731 5/20 0.40
▸ ALOX15 P16050 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ HDAC6 Q9UBN7 4/20 0.38
▸ HDAC3 O15379 1/20 0.38
▸ HDAC1 Q13547 1/20 0.38
▸ HDAC2 Q92769 1/20 0.38
▸ HDAC8 Q9BY41 1/20 0.38
▸ ADORA2A P29274 1/20 0.38
▸ MEN1 O00255 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ UTRN P46939 4/20 0.36
▸ HTR2B P41595 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29786775 0.93 NPC1 (0.48) NPC1RAB9AGFERCETPESR1
SCHEMBL18593330 0.90 NPC1 (0.52) NPC1RAB9AGFERCETPESR1
SCHEMBL18593328 0.87 NPC1 (0.48) NPC1RAB9AGFERCETPESR1
SCHEMBL18593334 0.86 NPC1 (0.43) NPC1RAB9AGFERCETPESR1
SCHEMBL28616475 0.86 ESR2 (0.56) ESR1ESR2HDAC6
SCHEMBL29460445 0.86 ESR2 (0.45) NPC1RAB9AGFERCETPESR1
SCHEMBL29819567 0.86 ESR2 (0.45) NPC1RAB9AGFERCETPESR1
SCHEMBL18593309 0.86 ESR2 (0.45) NPC1RAB9AGFERCETPESR1
SCHEMBL29612201 0.85 NPC1 (0.39) NPC1RAB9AGFERCETPESR1
SCHEMBL18593362 0.84 S1PR1 (0.46) NPC1RAB9AGFERESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9856208-B2 Method for producing an arene with an aromatic C—N bond ortho to an aromatic C—O bond THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY (CA) 2018-01-02 — — US disclosed
US-20170066711-A1 METHOD FOR PRODUCING AN ARENE WITH AN AROMATIC C-N BOND ORTHO TO AN AROMATIC C-O BOND THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY (CA) 2017-03-09 — — US disclosed
US-20170066711-A1 METHOD FOR PRODUCING AN ARENE WITH AN AROMATIC C-N BOND ORTHO TO AN AROMATIC C-O BOND THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY (CA) 2017-03-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170066711-A1 METHOD FOR PRODUCING AN ARENE WITH AN AROMATIC C-N BOND ORTHO TO AN AROMATIC C-O BOND AOX1, NOX4, NOXO1 NPC1 1680/4885RAB9A 769/4885GFER 1057/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback